Hopes rise for AstraZeneca cancer drug with start of new trial

August 29, 2014 8:31 AM

9 0

Hopes rise for AstraZeneca cancer drug with start of new trial

LONDON (Reuters) - Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer.

The drug, which is designed to help the immune system fight tumors, will be tested in 48 patients with advanced disease in the Phase II trial, according to an update on the website clinicaltrials.gov (here)

Read more

To category page

Loading...